🚨 Is your pharmaceutical brand prepared for FDA scrutiny?
Aspen Pharmacare Holdings recently faced a serious FDA warning highlighting significant violations in its manufacturing practices. These issues not only jeopardize product quality but also threaten access to vital medicines for patients.
Explore the implications of regulatory compliance on brand reputation and global supply in the full article!
#SyenzaNews #pharmaceuticals #regulatoryaffairs #MarketAccess